Fluminorex

This classification denotes an anorexiant with the molecular formula C10H9F3N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) LUO2Z7954T, chemically known as 2-oxazolamine, 4,5-dihydro-5-(4-(trifluoromethyl)-phenyl)- but more generally known as fluminorex, which bears US NIH Compound Identifier 24100. European Medicines Agency schedules Fluminorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07703MIG. The term FLUMINOREX is an International Non-Proprietary Name. FLUMINOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule fluminorex under HS 29349990 and SITC 51579. As of Q4 2014, FLUMINOREX remains US FDA's Preferred Term for this commodity. Fluminorex bears US NLM identifiers UMLS ID C2348685 and NCI Concept Code C72179. SMILES: C1C(OC(=N1)N)C2=CC=C(C=C2)C(F)(F)F.